iiinova — where your digital self keeps evolving

biorncluster.bsky.social @biorncluster.bsky.social · 09/10/2026

🌟bioRN Highlights of the week!🌟 -𝗛𝗮𝗿𝗻𝗲𝘀𝘀𝗶𝗻𝗴 𝗦𝘆𝗻𝘁𝗵𝗲𝘁𝗶𝗰 𝗖𝗲𝗹𝗹𝘂𝗹𝗮𝗿 𝗦𝘆𝘀𝘁𝗲𝗺𝘀 𝗮𝘀 𝗜𝗺𝗺𝘂𝗻𝗲 𝗖𝗲𝗹𝗹 𝗕𝗼𝗼𝘀𝘁𝗲𝗿𝘀 -𝗔𝗹𝗽𝗵𝗮𝗙𝗼𝗹𝗱 𝗗𝗮𝘁𝗮𝗯𝗮𝘀𝗲 𝗮𝗱𝗱𝘀 𝘃𝗶𝗿𝗮𝗹 𝗽𝗿𝗼𝘁𝗲𝗶𝗻 𝗰𝗼𝗺𝗽𝗹𝗲𝘅𝗲𝘀 𝘁𝗼 𝘀𝘂𝗽𝗽𝗼𝗿𝘁 𝗽𝗮𝗻𝗱𝗲𝗺𝗶𝗰 𝗽𝗿𝗲𝗽𝗮𝗿𝗲𝗱𝗻𝗲𝘀𝘀 - 𝗘𝘂𝗿𝗼𝗽𝗲𝗮𝗻 𝗖𝗼𝗺𝗺𝗶𝘀𝘀𝗶𝗼𝗻 𝗴𝗿𝗮𝗻𝘁𝘀 €𝟱𝟳 𝗺𝗶𝗹𝗹𝗶𝗼𝗻 𝘁𝗼 𝗰𝗿𝗶𝘁𝗶𝗰𝗮𝗹 𝗼𝗽𝗲𝗻 𝗱𝗮𝘁𝗮 𝗿𝗲𝘀𝗼𝘂𝗿𝗰𝗲𝘀 👉 More new at bioRN website: bit.ly/3Yd5fPR

000

biorncluster.bsky.social @biorncluster.bsky.social · 23/09/2026

We are delighted to welcome Dr. Philipp Baaske on stage at life - the biomedical convention 2027 (#life2027), 3rd Feb 2027 in #Heidelberg. Philipp brings a rare combination of founder experience and institutional perspectives to bioRN´s hightlight event! Join us: biorn.org/news-events/...

000

biorncluster.bsky.social @biorncluster.bsky.social · 11/08/2026

Highlights of the week - more news at biorn.org/news-events/... bioRN monthly newsletter: subscribe to the bioRN-newsletter and never miss out the monthly highlights of our vibrant life science ecosystem! biorn.org/newsletter/

000

biorncluster.bsky.social @biorncluster.bsky.social · 30/07/2026

bioRN Newsletter July: - The call for paper submissions for ‘life – the biomedical convention 2027’ is now open. - The new “Unified Hub for Healthcare Innovation - The newly founded Rhine-Neckar community for laboratory automation -t job-, event- and startup-opportunities biorn.org/newsletter/

010

biorncluster.bsky.social @biorncluster.bsky.social · 21/07/2026

bioRN news and highlights from our vibrant life science ecosystem. Get more news here: biorn.org/news-events/...

000

biorncluster.bsky.social @biorncluster.bsky.social · 07/07/2026

bioRN Life Science Cluster, BioM Biotech Cluster Development GmbH and ESMT Berlin are joining forces to create a Unified Hub for Healthcare Innovation. Learn more about the Unified Hub concept here: lnkd.in/e3DE-G3N Applications are open until 24 July.

010

biorncluster.bsky.social @biorncluster.bsky.social · 02/07/2026

Our June bioRN Newsletter is out! Explore the June edition here: ⏩https://biorn.org/newsletter/

000

biorncluster.bsky.social @biorncluster.bsky.social · 17/06/2026

Medical excellence alone is not enough. Prof. Dr. Hanns-Peter Knaebel´s impuls at MedTech Dialog in Mannheim: the real challenge is translating innovation into routine care and making it accessible at scale. Few regions combine clinical excellence, science and industry as closely as Rhine-Neckar.

Following the recent recognition of the Heidelberg - Mannheim hospital alliance as Germany's leading university hospital network, Prof. Dr. Hanns-Peter Knaebel shared a perspective that resonated strongly throughout the discussion.
Excellence alone is not enough.

Thank you to Prof. Dr. Hanns-Peter Knaebel, Lord Mayor Christian Specht, Dr. Paul Bäder, Irene Hövel and Jens Langejürgen for their valuable insights and perspectives, and to Katharina Fox and Jutta Dillschneider for hosting this important discussion.

000

biorncluster.bsky.social @biorncluster.bsky.social · 11/06/2026

Germany doesn't have a science problem. It has an implementation problem. Today, we had the pleasure of hosting the presentation of the EY German Biotechnology Report 2026 in Heidelberg. Insights and link to download the report for free: biorn.org/news-events/...

000

biorncluster.bsky.social @biorncluster.bsky.social · 29/05/2026

𝑯𝒂𝒑𝒑𝒚 𝑭𝒓𝒊𝒅𝒂𝒚 𝒘𝒊𝒕𝒉 𝒕𝒉𝒆 𝑯𝒊𝒈𝒉𝒍𝒊𝒈𝒉𝒕𝒔 𝒐𝒇 𝒕𝒉𝒆 𝑾𝒆𝒆𝒌! UKHD: bit.ly/43AvV02 VERAXA: bit.ly/4u25ZVU Prizes & more: bit.ly/4wRADUF

💥 𝗛𝗲𝗶𝗱𝗲𝗹𝗯𝗲𝗿𝗴-𝗯𝗮𝘀𝗲𝗱 𝗯𝗿𝗲𝗮𝗸𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝗶𝗻 𝗵𝗲𝗽𝗮𝘁𝗶𝘁𝗶𝘀 𝗗 𝘁𝗵𝗲𝗿𝗮𝗽𝘆: 𝗙𝗗𝗔 𝗮𝗽𝗽𝗿𝗼𝘃𝗲𝘀 𝗛𝗲𝗽𝗰𝗹𝘂𝗱𝗲𝘅 (𝗯𝘂𝗹𝗲𝘃𝗶𝗿𝘁𝗶𝗱𝗲)

The FDA has approved Hepcludex (bulevirtide) for chronic hepatitis D. The drug was largely developed by Prof. Stephan Urban at Heidelberg University, UKHD, and DZIF. It is the first approved therapy for hepatitis D and is now available in the U.S. following EU approval in 2020. Its development reflects ~30 years of translational research and collaboration between academia, funding bodies, and industry.

🚀 𝗩𝗘𝗥𝗔𝗫𝗔 𝗕𝗶𝗼𝘁𝗲𝗰𝗵 𝘀𝘁𝗿𝗲𝗻𝗴𝘁𝗵𝗲𝗻𝘀 𝗳𝗶𝗻𝗮𝗻𝗰𝗶𝗮𝗹 𝗽𝗼𝘀𝗶𝘁𝗶𝗼𝗻

VERAXA Biotech secured a $27.5M senior secured note and a $50M share purchase agreement to support its merger with Voyager Acquisition Corp. and advance its oncology pipeline (TCEs & ADCs). The company also applied for a Nasdaq listing under “VRXA.”

🏆 𝗧𝗵𝗿𝗲𝗲 𝗮𝘄𝗮𝗿𝗱𝘀 𝗳𝗼𝗿 𝗼𝘂𝗿 𝗿𝗲𝗴𝗶𝗼𝗻

💠 Dr. Christopher Carnie: ~€1.8M DFG Emmy Noether funding for research on chemotherapy-induced DNA damage in cancer cells
💠 Prof. Dr. Rohini Kuner: 2026 Jung Prize for Medicine (€300K) for chronic pain research and neuronal plasticity
💠 Prof. Dr. Henrik Kaessmann: 2026 Ernst Schering Prize (€50K) for evolutionary genomics and organ development research

000

biorncluster.bsky.social @biorncluster.bsky.social · 18/05/2026

Where is German biotech really heading in 2026? 🔹 Key insights from the EY German Biotech Report 2026 🔹 Impulse Prof. Dr. Jochen Maass 🔹 Discussion and networking with drinks & finger food Register here:https://biorn.org/news-events/events/presentation-of-the-german-biotechnology-report-2026/

010

biorncluster.bsky.social @biorncluster.bsky.social · 27/04/2026

Heidelberg/Mainz: Memorandum of Understanding - Strengthening one of Europe’s most powerful Life Science corridors biorn.org/heidelberg-u...

000

biorncluster.bsky.social @biorncluster.bsky.social · 17/02/2026

𝐋𝐨𝐨𝐤𝐢𝐧𝐠 𝐛𝐚𝐜𝐤 𝐚𝐭 𝐥𝐢𝐟𝐞 - the biomedical convention 𝟐𝟎𝟐𝟔: 𝐂𝐨𝐧𝐧𝐞𝐜𝐭𝐢𝐧𝐠 𝐭𝐡𝐞 𝐥𝐢𝐟𝐞 𝐬𝐜𝐢𝐞𝐧𝐜𝐞 𝐞𝐜𝐨𝐬𝐲𝐬𝐭𝐞𝐦 𝐚𝐜𝐫𝐨𝐬𝐬 𝐫𝐞𝐠𝐢𝐨𝐧𝐬 Heidelberg,4th Feb: 500 participants from academia, startups, industry, investment and policy made life a central platform for exchange, translation and collaboration. #life2026 #life2027

000

biorncluster.bsky.social @biorncluster.bsky.social · 21/08/2025

𝗪𝗼𝗿𝗸𝗶𝗻𝗴 𝗼𝗻 𝗻𝘂𝗰𝗹𝗲𝗶𝗰 𝗮𝗰𝗶𝗱 𝗾𝘂𝗮𝗻𝘁𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗹𝗼𝗼𝗸𝗶𝗻𝗴 𝗳𝗼𝗿 𝗮𝗰𝗰𝘂𝗿𝗮𝗰𝘆 𝗯𝗲𝘆𝗼𝗻𝗱 𝘁𝗵𝗲 𝗹𝗶𝗺𝗶𝘁𝘀 𝗼𝗳 𝘁𝗿𝗮𝗱𝗶𝘁𝗶𝗼𝗻𝗮𝗹 𝗣𝗖𝗥 𝗺𝗲𝘁𝗵𝗼𝗱𝘀? Join the 𝘀𝗺𝗮𝗿𝘁𝗟𝗮𝗯𝘀 𝗦𝘂𝗺𝗺𝗶𝘁 𝟮𝟬𝟮𝟱 🗓 𝗪𝗵𝗲𝗻: 24 September 2025 ⏰ 𝗧𝗶𝗺𝗲: 1:00 PM – 7:30 PM 📍 𝗪𝗵𝗲𝗿𝗲: @BioLabs Heidelberg 🎟 𝗙𝗿𝗲𝗲 𝗿𝗲𝗴𝗶𝘀𝘁𝗿𝗮𝘁𝗶𝗼𝗻: bit.ly/3GSQFse

000

biorncluster.bsky.social @biorncluster.bsky.social · 01/08/2025

Big news in research & biotech! 📜Stem cell-like cells drive pediatric blood cancer relapse (KiTZ, MMPU & DKFZ). 🚀BioLabs | TUM launches in Munich 💰DFG funds “DynOrg” at Heidelberg University to explore GPCR signaling in adaptation. #Biotech #Research #PediatricCancer #Munich #Heidelberg

010

biorncluster.bsky.social @biorncluster.bsky.social · 07/07/2025

𝐬𝐦𝐚𝐫𝐭𝐋𝐚𝐛𝐬 𝐒𝐮𝐦𝐦𝐢𝐭 𝟐𝟎𝟐𝟓 - 𝐎𝐩𝐭𝐢𝐦𝐢𝐬𝐞 𝐲𝐨𝐮𝐫 𝐰𝐨𝐫𝐤𝐟𝐥𝐨𝐰 Whether you’re exploring cutting-edge lab tech, smart automation tools, or digital lab solutions this summit is where innovation meets action. 🗓 24.09.25 🕐 1:00 -7:30 PM 📍BioLabs Heidelberg AGENDA : lnkd.in/eu5UVp7y REGISTER NOW: bit.ly/4lePwdE

000

biorncluster.bsky.social @biorncluster.bsky.social · 25/06/2025

𝗔𝗿𝗲 𝘆𝗼𝘂 𝗿𝗲𝗮𝗱𝘆 𝘁𝗼 𝗿𝗲𝘁𝗵𝗶𝗻𝗸 𝗹𝗮𝗯 𝘄𝗼𝗿𝗸𝗳𝗹𝗼𝘄𝘀? 𝗝𝗼𝗶𝗻 𝘂𝘀 𝗮𝘁 𝘁𝗵𝗲 𝗳𝗶𝗿𝘀𝘁-𝗲𝘃𝗲𝗿 𝘀𝗺𝗮𝗿𝘁𝗟𝗮𝗯𝘀 𝗦𝘂𝗺𝗺𝗶𝘁 𝟮𝟬𝟮𝟱! 𝗕𝘂𝘁 𝘁𝗵𝗮𝘁’𝘀 𝗷𝘂𝘀𝘁 𝘁𝗵𝗲 𝗯𝗲𝗴𝗶𝗻𝗻𝗶𝗻𝗴. Workflow optimization is the focus – and we’re bringing in the experts on stage and on the expo floor: 𝗿𝗲𝗴𝗶𝘀𝘁𝗲𝗿 here👉https://biorn.org/news-events/smartlabs-summit-2025/

000

biorncluster.bsky.social @biorncluster.bsky.social · 28/05/2025

𝐋𝐢𝐟𝐞 𝐰𝐢𝐭𝐡 𝐭𝐰𝐨 𝐗 𝐜𝐡𝐫𝐨𝐦𝐨𝐬𝐨𝐦𝐞𝐬: agneseloda.bsky.social at bioRN Lounge: 💡 Women are incredibly variable thanks to inactivation of X chromosome 💡 Xist RNA could regulate dosage of Xlinked genes throughout life 💡 Natural fluctuations in Xist RNA could influence protein dosage in women. bit.ly/43pSDaI

000

biorncluster.bsky.social @biorncluster.bsky.social · 12/05/2025

𝐛𝐢𝐨𝐑𝐍 𝐌𝟐𝐌 𝐟𝐞𝐚𝐭𝐮𝐫𝐢𝐧𝐠 𝐁𝐢𝐨𝐓𝐡𝐫𝐮𝐬𝐭 WHEN: 3 June , 12:00-12:40 pm WHERE: digital via zoom Register here: biorn.org/news-events/...

000

biorncluster.bsky.social @biorncluster.bsky.social · 12/05/2025

🌟 Happy Saturday with the Hioghlights of the Week! 🌟 UKHD x Mannheim merger clears hurdle: bit.ly/43lTMRU VERAXA + OmniAb join forces on cancer therapy: bit.ly/3Z9tHD2 Childhood brain tumors traced to early nerve cells: bit.ly/3F2ba4W More: bit.ly/3Yd5fPR

000

biorncluster.bsky.social @biorncluster.bsky.social · 06/05/2025

🎸 bioRN busy in Basel 2nd day rocking the floor at the Swiss Biotech Days together with our members Heidelberg Pharma AG; Sciomics: AGC Biologics; BIMOVIS and Trans-Duodenal Concepts GmbH. Not in Basel? 👉 Join us at one of our next events: lnkd.in/e69jHZcw

000

biorncluster.bsky.social @biorncluster.bsky.social · 05/05/2025

𝐖𝐡𝐢𝐜𝐡 𝐩𝐚𝐭𝐡𝐬 𝐰𝐢𝐥𝐥 𝐥𝐞𝐚𝐝 𝐆𝐞𝐫𝐦𝐚𝐧 𝐛𝐢𝐨𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐭𝐨 𝐬𝐮𝐜𝐜𝐞𝐬𝐬? 𝐄𝐘 𝐆𝐞𝐫𝐦𝐚𝐧 𝐁𝐢𝐨𝐭𝐞𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 𝟐𝟎𝟐𝟓 𝐑𝐨𝐚𝐝𝐬𝐡𝐨𝐰 German Biotech Report - Swiss Biotech Report - bioRN facts and figures 📍When: May 22, 4:00–5:30 PM 📍 Where: Business Development Center (BDC), Heidelberg ✅ Register here: biorn.org/news-events/...

000

biorncluster.bsky.social @biorncluster.bsky.social · 04/04/2025

🌟Highlights of the week🌟 📜 Preventing Defective Protein Blueprints: bit.ly/43zzgxO 🚀 Robot navigates precisely to changes in the lungs: bit.ly/42hJwZ8 🏆 Heinz Maier-Leibnitz Prize for Lukas Bunse: bit.ly/42h4s2m 👉 Find all news and much more in our newslounge at bioRN website: bit.ly/3Yd5fPR

Highlights of the bioRN Life Science Cluster in the Rhine-Neckar region

000

biorncluster.bsky.social @biorncluster.bsky.social · 26/03/2025

𝐅𝐚𝐬𝐭 𝐚𝐧𝐝 𝐅𝐚𝐢𝐫 𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐀𝐜𝐜𝐞𝐬𝐬 𝐭𝐨 𝐒𝐭𝐮𝐝𝐢𝐞𝐬 𝐚𝐧𝐝 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 The bioRN Lounge had the great honor of hosting Ursula Weyrich for an insightful presentation on @dkfz.bsky.social and its Clinical Research Network @nct-heidelberg.bsky.social. ▶️ Missed it? Register for next lnkd.in/eAvUMFVX

010

biorncluster.bsky.social @biorncluster.bsky.social · 17/03/2025

𝐖𝐚𝐭𝐜𝐡 𝐭𝐡𝐞 𝐧𝐞𝐰 𝐌𝟐𝐌 𝐢𝐧𝐭𝐞𝐫𝐯𝐢𝐞𝐰 𝐰𝐢𝐭𝐡 𝐨𝐮𝐫 𝐦𝐞𝐦𝐛𝐞𝐫 𝐀𝐫𝐜𝐨𝐧𝐝𝐢𝐬 - 𝐧𝐨𝐰 𝐚𝐯𝐚𝐢𝐥𝐚𝐛𝐥𝐞 𝐨𝐧 𝐝𝐞𝐦𝐚𝐧𝐝 🎦https://lnkd.in/ekWjHq_A M2M – Member to member’ showcases bioRN companies, institutions, and players in the network. Find more information about the upcoming bioRN M2M interviews at lnkd.in/e69jHZcw

000

biorncluster.bsky.social @biorncluster.bsky.social · 13/03/2025

𝐉𝐨𝐢𝐧 𝐮𝐬 𝐚𝐭 𝐭𝐡𝐞 𝐛𝐢𝐨𝐑𝐍 𝐕𝐢𝐥𝐥𝐚𝐠𝐞 𝐚𝐧𝐝 𝐞𝐱𝐩𝐥𝐨𝐫𝐞 𝐭𝐡𝐞 𝐯𝐢𝐛𝐫𝐚𝐧𝐭 𝐡𝐞𝐚𝐫𝐭 💚 𝐨𝐟 𝐥𝐢𝐟𝐞 𝐬𝐜𝐢𝐞𝐧𝐜𝐞𝐬 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 - 𝐆𝐞𝐫𝐦𝐚𝐧 𝐁𝐢𝐨𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐃𝐚𝐲𝐬 𝟐𝟎𝟐𝟓 Visit the German Biotechnology Days, 9-10 April 2025, Heidelberg Congress Center Registration: www.german-biotech.day/registration...

000

biorncluster.bsky.social @biorncluster.bsky.social · 07/03/2025

𝑯𝒊𝒈𝒉𝒍𝒊𝒈𝒉𝒕𝒔 𝒐𝒇 𝒕𝒉𝒆 𝑾𝒆𝒆𝒌! 📜 AI detects developmental disorders early by analyzing baby movements 🚀 NMI TT in Reutlingen and partners develop a precise method to analyze circulating tumor cells 🏆 Frank Winkler receives the Brain Prize 2025 👉 More the news and much more here bit.ly/3Yd5fPR

000

biorncluster.bsky.social @biorncluster.bsky.social · 24/02/2025

🌟 bioRN Highlights 🌟 📜 A special puppeteer holds the strings to liver cells’ identityhttps://bit.ly/3D4ILKt 💰 Funding for globally accessible rapid identification of tumor cells bit.ly/4kaA8ik 🚀BioMed X Institute Launches New Institute in Barbadoshttps://bit.ly/3QwmJU9 👉more news: bit.ly/3Yd5fPR

000

biorncluster.bsky.social @biorncluster.bsky.social · 14/02/2025

𝑯𝒊𝒈𝒉𝒍𝒊𝒈𝒉𝒕𝒔 𝒐𝒇 𝒕𝒉𝒆 𝑾𝒆𝒆𝒌! When Cancer Cells Escape the Bone Marrow, Dangerous Diversity Emerges bit.ly/3QjGLku How the HIV-1 Capsid Breaches the Human Nucleus Barrier: bit.ly/4k0HIM6 Therapeutic Designer Peptide to Combat Acute Heart Muscle Weakness. bit.ly/4jYGQHR >bioRN newslounge bit.ly/3Yd5fPR

000

biorncluster.bsky.social @biorncluster.bsky.social · 05/02/2025

𝗯𝗶𝗼𝗥𝗡 𝗩𝗶𝗹𝗹𝗮𝗴𝗲 at the German Biotechnology Days. Showcasing our vibrant life science ecosystem, the scientific excellence, startup friendliness and high industry density! 👉 Register now and be part of the highlight event in Heidelberg: www.german-biotech.day

000

biorncluster.bsky.social @biorncluster.bsky.social · 29/01/2025

Yesterday we had the pleasure of welcoming Peter Loskill (@MicroOrgano-Lab) at the first bioRN Lounge with his impuls on >>𝐎𝐫𝐠𝐚𝐧-𝐨𝐧-𝐂𝐡𝐢𝐩: 𝐍𝐞𝐱𝐭-𝐆𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐨𝐧 𝐡𝐮𝐦𝐚𝐧 𝐌𝐨𝐝𝐞𝐥 𝐒𝐲𝐬𝐭𝐞𝐦𝐬 𝐟𝐨𝐫 𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐚𝐧𝐝 𝐩𝐞𝐫𝐬𝐨𝐧𝐚𝐥𝐢𝐳𝐞𝐝 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞<<. Stay tuned about the bioRN events: biorn.org/news-events/...

000

biorncluster.bsky.social @biorncluster.bsky.social · 27/01/2025

Highlights of last week: 🚀 BioChatter: making large language models accessible for biomedical research bit.ly/3EiRaKp 📜 How the Ebola virus multiplies in cells bit.ly/4gb0NIr 🏆 New weapons against viruses bit.ly/4arRnHn 👉 Find all news in our newslounge at bioRN website: bit.ly/3Yd5fPR

000

biorncluster.bsky.social @biorncluster.bsky.social · 17/01/2025

📜 HI-STEM: New study investigates how circulating tumor cells drive metastasis in breast cancer. 📜 Exploration of Novel Biomarkers for Neurodegenerative Diseases Using Proteomic Analysis and Ligand-Binding Assays 🚀BioMed X and Daiichi Sankyo collaborate in Cancer Therapy biorn.org/news-events/...

000

biorncluster.bsky.social @biorncluster.bsky.social · 17/01/2025

𝟖 𝐬𝐞𝐜𝐨𝐧𝐝𝐬 𝐭𝐨 𝐬𝐭𝐚𝐧𝐝 𝐨𝐮𝐭 𝐟𝐫𝐨𝐦 𝐭𝐡𝐞 𝐜𝐫𝐨𝐰𝐝 - 𝐭𝐡𝐞 𝐭𝐡𝐞 𝐚𝐫𝐭 𝐨𝐟 𝐬𝐜𝐢𝐞𝐧𝐭𝐢𝐟𝐢𝐜 𝐬𝐭𝐨𝐫𝐲𝐭𝐞𝐥𝐥𝐢𝐧𝐠 bioRN showcased Nanobot in an interview within the M2M Member to Member format: 🎦: biorn.org/news-events/... M2M showcases bioRN companies, institutions, and players in the network.

010